BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35610649)

  • 1. Effect of erythromycin on mortality and the host response in critically ill patients with sepsis: a target trial emulation.
    Reijnders TDY; Peters-Sengers H; van Vught LA; Uhel F; Bonten MJM; Cremer OL; Schultz MJ; Stuiver MM; van der Poll T;
    Crit Care; 2022 May; 26(1):151. PubMed ID: 35610649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D Supplementation during Intensive Care Unit Stay Is Associated with Improved Outcomes in Critically Ill Patients with Sepsis: A Cohort Study.
    Yang B; Zhu Y; Zheng X; Li T; Niu K; Wang Z; Lu X; Zhang Y; Shen C
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Dexamethasone and Delirium in Critically Ill Patients: A Retrospective Cohort Study of a Large Clinical Database.
    Wu Z; Li H; Liao K; Wang Y
    J Surg Res; 2021 Jul; 263():89-101. PubMed ID: 33639374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.
    Warttig S; Alderson P; Evans DJ; Lewis SR; Kourbeti IS; Smith AF
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012404. PubMed ID: 29938790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between fluid balance and mortality for heart failure and sepsis: a propensity score-matching analysis.
    Zhang B; Guo S; Fu Z; Wu N; Liu Z
    BMC Anesthesiol; 2022 Oct; 22(1):324. PubMed ID: 36273128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyethyl starch for fluid resuscitation in critically ill patients.
    Bagshaw SM; Chawla LS
    Can J Anaesth; 2013 Jul; 60(7):709-13. PubMed ID: 23604905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis.
    van Vught LA; Klein Klouwenberg PM; Spitoni C; Scicluna BP; Wiewel MA; Horn J; Schultz MJ; Nürnberg P; Bonten MJ; Cremer OL; van der Poll T;
    JAMA; 2016 Apr; 315(14):1469-79. PubMed ID: 26975785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].
    Chen M; Hu B; Li Q; Liu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):246-51. PubMed ID: 29917340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of magnesium sulfate use with mortality in critically ill patients with sepsis: a retrospective propensity score-matched cohort study.
    Gu WJ; Duan XJ; Liu XZ; Cen Y; Tao LY; Lyu J; Yin HY
    Br J Anaesth; 2023 Nov; 131(5):861-870. PubMed ID: 37684164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of early heparin therapy on outcomes in critically ill patients with sepsis-induced coagulopathy.
    Huang JJ; Zou ZY; Zhou ZP; Liu Y; Yang ZJ; Zhang JJ; Luan YY; Yao YM; Wu M
    Front Pharmacol; 2023; 14():1173893. PubMed ID: 37256226
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
    Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
    Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*.
    Raghunathan K; Shaw A; Nathanson B; Stürmer T; Brookhart A; Stefan MS; Setoguchi S; Beadles C; Lindenauer PK
    Crit Care Med; 2014 Jul; 42(7):1585-91. PubMed ID: 24674927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
    Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
    Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot randomised controlled trial in intensive care patients comparing 7 days' treatment with empirical antibiotics with 2 days' treatment for hospital-acquired infection of unknown origin.
    Scawn N; Saul D; Pathak D; Matata B; Kemp I; Stables R; Lane S; Haycox A; Houten R
    Health Technol Assess; 2012 Sep; 16(36):i-xiii, 1-70. PubMed ID: 23010339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients.
    Japiassú AM; Amâncio RT; Mesquita EC; Medeiros DM; Bernal HB; Nunes EP; Luz PM; Grinsztejn B; Bozza FA
    Crit Care; 2010; 14(4):R152. PubMed ID: 20698966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Route of nutrition and risk of blood stream infections in critically ill patients; a comparative study.
    Gavri C; Kokkoris S; Vasileiadis I; Oeconomopoulou AC; Kotanidou A; Nanas S; Routsi C
    Clin Nutr ESPEN; 2016 Apr; 12():e14-e19. PubMed ID: 28531664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between statin therapy and outcomes in critically ill patients: a nested cohort study.
    Al Harbi SA; Tamim HM; Arabi YM
    BMC Clin Pharmacol; 2011 Aug; 11():12. PubMed ID: 21819615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monocyte/lymphocyte ratio as a predictor of 30-day mortality and adverse events in critically ill patients: analysis of the MIMIC-III database].
    Li Y; Liu Y; Zhou C; Zhang Z; Zuo X; Li J; Cao Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 May; 33(5):582-586. PubMed ID: 34112297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of hypophosphatemia on the prognosis of critically ill patients].
    Jiang J; Bao J; Yang R; Zhang H; Wang Y; Zhang H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Aug; 34(8):858-862. PubMed ID: 36177931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.